Analysts Viewpoint Analysts review Sanofi ADR’s rating Following these proceedings, Exane BNP Paribas initiated its Sanofi ADR [SNY] rating to an Outperform in a research note published
Insiders Updates Examining the Potential Price Growth of Sanofi ADR (SNY) While this happened, Exane BNP Paribas initiated its Sanofi ADR [SNY] rating to an Outperform in a research note published